Stocks › BHVN
Biohaven BHVN
US equityMarket cap rank #2714
$12.39 −$1.26 (-9.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.51 +0.97%
Open$13.26
Prev close$13.65
Day range$12.31 – $13.75
Volume2.39M
Market cap$1.87B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$126.42M+25.4% YoY
Net profit-$129.28M+25.5% YoY
Diluted EPS-$0.86+47.6% YoY
Free cash flow-$107.03M+26.6% YoY
Operating cash flow-$106.85M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on assets-161.3%
Current ratio3.05
Liabilities / assets137.3%
Cash & investments$161.13M
Total debt$295.70M
Net cash (debt)-$134.58M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $126.42M | $124.90M | $130.43M | $745.38M | $142.73M |
| Selling and Admin Expenses | $24.57M | $24.09M | $26.60M | $110.31M | $20.79M |
| -General & Admin Expense | $24.57M | $24.09M | $26.60M | $110.31M | $20.79M |
| Research & Development | $101.85M | $100.81M | $103.83M | $635.07M | $121.95M |
| Operating Profit | -$126.42M | -$124.90M | -$130.43M | -$745.38M | -$142.73M |
| Other Income (Expense) | -$2.92M | -$12.02M | $168,000.00 | $8.00M | -$2.47M |
| Other Non-Operating Income (Expenses) | -$2.92M | -$12.02M | $168,000.00 | $8.00M | -$2.47M |
| Pretax Profit | -$129.34M | -$136.92M | -$130.26M | -$737.38M | -$145.20M |
| Tax | -$64,000.00 | $391,000.00 | $272,000.00 | $1.44M | $351,000.00 |
| Net Profit | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| Profit from Continuing Operations | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| Net Income to Parent Company | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| Net Income to Common Stockholders | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| Basic EPS | -$0.86 | -$0.91 | -$0.88 | -$6.86 | -$1.21 |
| Diluted EPS | -$0.86 | -$0.91 | -$0.88 | -$6.86 | -$1.21 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $263.68M | $370.74M | $466.41M | $451.45M | $451.45M |
| Total Current Assets | $191.51M | $296.56M | $385.65M | $368.33M | $368.33M |
| Cash and Cash Equivalents & Short-Term Investments | $161.13M | $267.87M | $347.82M | $319.14M | $319.14M |
| -Cash and Cash Equivalents | $95.75M | $238.03M | $273.07M | $229.96M | $229.96M |
| -Short Term Investments | $65.37M | $29.83M | $74.74M | $89.18M | $89.18M |
| Prepaid Assets | $27.57M | $27.04M | $34.67M | $47.02M | $47.02M |
| Other Current Assets | $2.82M | $1.65M | $3.17M | $2.17M | $2.17M |
| Total Non-Current Assets | $72.16M | $73.89M | $80.76M | $83.12M | $83.12M |
| Net PPE | $50.23M | $51.60M | $58.66M | $61.02M | $61.02M |
| -Gross PPE | $68.26M | $69.05M | $75.49M | $77.15M | $77.15M |
| -Accumulated Depreciation | -$18.02M | -$17.46M | -$16.83M | -$16.13M | -$16.13M |
| Goodwill and Other Intangible Assets | $19.79M | $19.79M | $19.79M | $19.79M | $19.79M |
| -Goodwill | $1.39M | $1.39M | $1.39M | $1.39M | $1.39M |
| -Other Intangible Assets | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M |
| Other Non-Current Assets | $2.14M | $2.50M | $2.31M | $2.31M | $2.31M |
| Total Liabilities | $361.92M | $358.52M | $336.91M | $399.38M | $399.38M |
| Total Current Liabilities | $62.77M | $62.66M | $52.08M | $115.93M | $115.93M |
| Payables | $13.53M | $12.11M | $10.42M | $11.64M | $11.64M |
| -Accounts Payable | $13.53M | $12.11M | $10.42M | $11.64M | $11.64M |
| Current Accrued Expenses | $32.39M | $37.65M | $31.33M | $39.04M | $39.04M |
| Short-Term Debt and Capital Lease Obligation | $4.74M | $4.67M | $5.90M | $5.76M | $5.76M |
| -Current Capital Lease Obligation | $4.74M | $4.67M | $5.90M | $5.76M | $5.76M |
| Total Non-Current Liabilities | $299.16M | $295.86M | $284.83M | $283.44M | $283.44M |
| Long Term Debt and Capital Lease Obligation | $295.70M | $292.37M | $280.28M | $278.86M | $278.86M |
| -Long Term Debt | $264.29M | $259.48M | $241.91M | $238.90M | $238.90M |
| -Long Term Capital Lease Obligation | $31.41M | $32.89M | $38.36M | $39.96M | $39.96M |
| Other Non-Current Liabilities | $3.46M | $3.49M | $4.56M | $4.58M | $4.58M |
| Total Equity | -$98.25M | $12.22M | $129.50M | $52.07M | $52.07M |
| Stockholders' Equity | -$98.25M | $12.22M | $129.50M | $52.07M | $52.07M |
| Capital Stock | $2.14B | $2.14B | $2.13B | $1.93B | $1.93B |
| -Common Stock | $2.14B | $2.14B | $2.13B | $1.93B | $1.93B |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $238.84M | $220.37M | $203.36M | $193.98M | $193.98M |
| Retained Earnings | -$2.48B | -$2.35B | -$2.22B | -$2.08B | -$2.08B |
| Gains/Losses Not Affecting Retained Earnings | $5.35M | $5.38M | $8.30M | $8.35M | $8.35M |
| Other Current Liabilities | – | – | – | $42.71M | $42.71M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$106.85M | -$85.10M | -$149.92M | -$609.44M | -$130.66M |
| Net cash flow from continuing operations | -$106.85M | -$85.10M | -$149.92M | -$609.44M | -$130.66M |
| Net Income from Continuing Operations | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| Depreciation & Depletion & Amortization | $2.22M | $2.26M | $2.37M | $9.92M | $2.57M |
| Other Non-Cash Items | -$18.06M | $17.13M | $21,000.00 | $5.02M | $5.58M |
| Change in Working Capital | -$2.82M | $16.67M | -$53.07M | $1.36M | -$9.83M |
| -Change in Prepaid Assets | -$1.41M | $7.52M | $12.56M | $3.53M | $8.82M |
| -Change in Payables and Accrued Expense | -$1.41M | $9.15M | -$65.64M | -$2.17M | -$18.64M |
| Net cash flow from investing | -$35.33M | $44.82M | $15.21M | $300.56M | -$13.74M |
| Net Cash Flow from Continuing Investing Activities | -$35.33M | $44.82M | $15.21M | $300.56M | -$13.74M |
| Net PPE Purchase and Sale | -$180,000.00 | -$454,000.00 | $0.00 | -$715,000.00 | -$8,000.00 |
| Net Investment Purchase and Sale | -$35.15M | $45.28M | $15.21M | $303.13M | -$13.73M |
| Financing Cash Flow | $211,000.00 | $3.80M | $179.02M | $439.12M | $188.80M |
| Net Cash Flow from Continuing Financing Activities | $211,000.00 | $3.80M | $179.02M | $439.12M | $188.80M |
| Net Issuance Payments Of Debt | $0.00 | – | – | $250.00M | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $178.88M | $189.18M | $189.18M |
| Proceeds from Stock Option Exercised | $211,000.00 | $3.80M | $132,000.00 | $1.83M | $265,000.00 |
| Ending Cash Balance | $98.66M | $240.63M | $277.11M | $232.78M | $232.78M |
| Net Change in Cash | -$141.97M | -$36.48M | $44.31M | $130.24M | $44.40M |
| Beginning Cash Balance | $240.63M | $277.11M | $232.78M | $102.54M | $188.38M |
| Effect of Exchange Rate Changes | $0.00 | $3,000.00 | $16,000.00 | -$3,000.00 | $0.00 |
| Free Cash Flow | -$107.03M | -$85.55M | -$149.92M | -$610.15M | -$130.67M |
| Gain/Loss from Continuing Operations | – | – | – | $9.43M | $20.70M |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
| Net Other Investing Changes | – | – | – | -$1.85M | $0.00 |
| Net Other Financing Charges | – | – | – | -$1.89M | -$644,000.00 |
No comments yet — be the first to weigh in on BHVN.
Sign in to join the discussion.